BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mitchell ED, Czoski Murray C, Meads D, Minton J, Wright J, Twiddy M. Clinical and cost-effectiveness, safety and acceptability of community intravenous antibiotic service models: CIVAS systematic review. BMJ Open 2017;7:e013560. [PMID: 28428184 DOI: 10.1136/bmjopen-2016-013560] [Cited by in Crossref: 31] [Cited by in F6Publishing: 34] [Article Influence: 7.8] [Reference Citation Analysis]
Number Citing Articles
1 Foy F, Luna G, Martinez J, Nizich Z, Seet J, Lie K, Sunderland B, Czarniak P. An investigation of the stability of meropenem in elastomeric infusion devices. Drug Des Devel Ther 2019;13:2655-65. [PMID: 31447546 DOI: 10.2147/DDDT.S212052] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
2 Mansour O, Arbaje AI, Townsend JL. Patient Experiences With Outpatient Parenteral Antibiotic Therapy: Results of a Patient Survey Comparing Skilled Nursing Facilities and Home Infusion. Open Forum Infect Dis 2019;6:ofz471. [PMID: 32128322 DOI: 10.1093/ofid/ofz471] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
3 Townsend J, Keller S, Tibuakuu M, Thakker S, Webster B, Siegel M, Psoter KJ, Mansour O, Perl TM. Outpatient Parenteral Therapy for Complicated Staphylococcus aureus Infections: A Snapshot of Processes and Outcomes in the Real World. Open Forum Infect Dis 2018;5:ofy274. [PMID: 30488039 DOI: 10.1093/ofid/ofy274] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
4 Dabrowski H, Wickham H, De S, Underwood J, Morris-Jones S, Logan S, Marks M, Pollara G. Clinical outcomes of teicoplanin use in the OPAT setting. Int J Antimicrob Agents 2020;55:105888. [PMID: 31923571 DOI: 10.1016/j.ijantimicag.2020.105888] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
5 Stelmaszczyk-Emmel A, Sosnowska A, Kurkowiak J, Sagała M, Zawadzka-Głos L, PyrŻak B, Demkow U. Utility of leucocyte antigens in distinguishing between bacterial and viral infection in children. Cent Eur J Immunol 2018;43:262-9. [PMID: 30588170 DOI: 10.5114/ceji.2018.80044] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
6 Fields BE, Whitney RL, Bell JF. Managing Home Infusion Therapy. Am J Nurs 2020;120:53-9. [PMID: 33214375 DOI: 10.1097/01.NAJ.0000724252.22812.a2] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 García-Queiruga M, Feal Cortizas B, Lamelo Alfonsín F, Pertega Diaz S, Martín-Herranz I. Continuous infusion of antibiotics using elastomeric pumps in the hospital at home setting. Rev Esp Quimioter 2021;34:200-6. [PMID: 33724755 DOI: 10.37201/req/122.2020] [Reference Citation Analysis]
8 Ceniceros AG, Shridhar N, Fazzari M, Felsen U, Fox AD. Low Use of Outpatient Parenteral Antimicrobial Therapy for Drug Use-Associated Infective Endocarditis in an Urban Hospital System. Open Forum Infect Dis 2021;8:ofab083. [PMID: 33796596 DOI: 10.1093/ofid/ofab083] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Psaltikidis EM, Silva END, Moretti ML, Trabasso P, Stucchi RSB, Aoki FH, Cardoso LGO, Höfling CC, Bachur LF, Ponchet DDF, Colombrini MRC, Tozzi CS, Ramos RF, Costa SMQ, Resende MR. Cost-utility analysis of outpatient parenteral antimicrobial therapy (OPAT) in the Brazilian national health system. Expert Rev Pharmacoecon Outcomes Res 2019;19:341-52. [PMID: 30362845 DOI: 10.1080/14737167.2019.1541404] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
10 Habayeb H, Grundy C, Rangaiah J, Van de Velde S. Continuous beta-lactam intravenous antibiotic infusions for outpatient parenteral antimicrobial therapy. Int J Antimicrob Agents 2018;52:436-7. [PMID: 29751118 DOI: 10.1016/j.ijantimicag.2018.05.001] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
11 Boese CK, Lechler P, Frink M, Hackl M, Eysel P, Ries C. [Cost analysis of inpatient versus outpatient intravenous antibiotic treatment for periprosthetic joint infections : A simulation]. Orthopade 2021;50:150-8. [PMID: 32076752 DOI: 10.1007/s00132-020-03889-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Leonardsen AL, Lunde EM, Smith ST, Olsen GL. Patient experiences with peripherally inserted venous catheters- A cross-sectional, multicentre study in Norway. Nurs Open 2020;7:760-7. [PMID: 32257263 DOI: 10.1002/nop2.448] [Reference Citation Analysis]
13 Sumpter C, Russell CD, Mackintosh C. Inequitable access to an outpatient parenteral antimicrobial therapy service: linked cross-sectional study. Int J Equity Health 2020;19:150. [PMID: 32873291 DOI: 10.1186/s12939-020-01261-w] [Reference Citation Analysis]
14 Mahoney MV, Ryan KL, Alexander BT. Evaluation of OPAT in the Age of Antimicrobial Stewardship. Curr Treat Options Infect Dis 2020;12:158-77. [DOI: 10.1007/s40506-020-00217-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
15 Fanucchi LC, Walsh SL, Thornton AC, Lofwall MR. Integrated outpatient treatment of opioid use disorder and injection-related infections: A description of a new care model. Prev Med 2019;128:105760. [PMID: 31251946 DOI: 10.1016/j.ypmed.2019.105760] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 4.5] [Reference Citation Analysis]
16 Marks M, Bell LCK, Jones I, Rampling T, Kranzer K, Morris-Jones S, Logan S, Pollara G. Clinical and Economic Impact of Implementing OVIVA Criteria on Patients With Bone and Joint Infections in Outpatient Parenteral Antimicrobial Therapy. Clin Infect Dis 2020;71:207-10. [PMID: 31603189 DOI: 10.1093/cid/ciz991] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
17 Li A, Rosenthal ES, Rapoport AB, Rowley CF. Opioid use disorder and infectious complications in persons who inject drugs. Int Anesthesiol Clin 2020;58:4-11. [PMID: 32073421 DOI: 10.1097/AIA.0000000000000276] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
18 Wee LE, Sundarajoo M, Quah WF, Farhati A, Huang JY, Chua YY. Health-related quality of life and its association with outcomes of outpatient parenteral antibiotic therapy. Eur J Clin Microbiol Infect Dis 2020;39:765-72. [PMID: 31873862 DOI: 10.1007/s10096-019-03787-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Dimitrova M, Gilchrist M, Seaton RA. Outpatient parenteral antimicrobial therapy (OPAT) versus inpatient care in the UK: a health economic assessment for six key diagnoses. BMJ Open 2021;11:e049733. [PMID: 34588251 DOI: 10.1136/bmjopen-2021-049733] [Reference Citation Analysis]
20 Wee LE, Sundarajoo M, Quah WF, Farhati A, Huang JY, Chua YY. Sociodemographic and clinical factors associated with acceptance of outpatient parenteral antibiotic therapy in a Singapore tertiary hospital from 2014 to 2017. Eur J Clin Microbiol Infect Dis 2019;38:277-84. [PMID: 30430375 DOI: 10.1007/s10096-018-3424-2] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
21 Mansour O, Heslin J, Townsend JL. Impact of the implementation of a nurse-managed outpatient parenteral antibiotic therapy (OPAT) system in Baltimore: a case study demonstrating cost savings and reduction in re-admission rates. J Antimicrob Chemother 2018;73:3181-8. [PMID: 30085088 DOI: 10.1093/jac/dky294] [Cited by in Crossref: 15] [Cited by in F6Publishing: 10] [Article Influence: 7.5] [Reference Citation Analysis]
22 Krein SL, Harrod M, Weston LE, Garlick BR, Quinn M, Fletcher KE, Chopra V. Comparing peripherally inserted central catheter-related practices across hospitals with different insertion models: a multisite qualitative study. BMJ Qual Saf 2021;30:628-38. [PMID: 33361343 DOI: 10.1136/bmjqs-2020-011987] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Keyloun KR, Weber DJ, Gardstein BM, Berger A, Gillard P, Ganz ML. Economic burden of hospital admissions for patients with acute bacterial skin and skin structure infections in the United States. Hosp Pract (1995) 2018;46:278-86. [PMID: 30067108 DOI: 10.1080/21548331.2018.1506673] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
24 Suzuki J, Johnson J, Montgomery M, Hayden M, Price C. Outpatient Parenteral Antimicrobial Therapy Among People Who Inject Drugs: A Review of the Literature. Open Forum Infect Dis 2018;5:ofy194. [PMID: 30211247 DOI: 10.1093/ofid/ofy194] [Cited by in Crossref: 40] [Cited by in F6Publishing: 38] [Article Influence: 13.3] [Reference Citation Analysis]
25 Twiddy M, Czoski Murray CJ, Mason SJ, Meads D, Wright JM, Mitchell ED, Minton J; CIVAS study team. A qualitative study of patients' feedback about Outpatient Parenteral Antimicrobial Therapy (OPAT) services in Northern England: implications for service improvement. BMJ Open 2018;8:e019099. [PMID: 29326190 DOI: 10.1136/bmjopen-2017-019099] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 4.3] [Reference Citation Analysis]
26 Quintens C, Steffens E, Jacobs K, Schuermans A, Van Eldere J, Lagrou K, De Munter P, Derdelinckx I, Peetermans WE, Spriet I. Efficacy and safety of a Belgian tertiary care outpatient parenteral antimicrobial therapy (OPAT) program. Infection 2020;48:357-66. [DOI: 10.1007/s15010-020-01398-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
27 Serota DP, Chueng TA, Schechter MC. Applying the Infectious Diseases Literature to People who Inject Drugs. Infect Dis Clin North Am 2020;34:539-58. [PMID: 32782101 DOI: 10.1016/j.idc.2020.06.010] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
28 Orlandi RR, Kingdom TT, Smith TL, Bleier B, DeConde A, Luong AU, Poetker DM, Soler Z, Welch KC, Wise SK, Adappa N, Alt JA, Anselmo-Lima WT, Bachert C, Baroody FM, Batra PS, Bernal-Sprekelsen M, Beswick D, Bhattacharyya N, Chandra RK, Chang EH, Chiu A, Chowdhury N, Citardi MJ, Cohen NA, Conley DB, DelGaudio J, Desrosiers M, Douglas R, Eloy JA, Fokkens WJ, Gray ST, Gudis DA, Hamilos DL, Han JK, Harvey R, Hellings P, Holbrook EH, Hopkins C, Hwang P, Javer AR, Jiang RS, Kennedy D, Kern R, Laidlaw T, Lal D, Lane A, Lee HM, Lee JT, Levy JM, Lin SY, Lund V, McMains KC, Metson R, Mullol J, Naclerio R, Oakley G, Otori N, Palmer JN, Parikh SR, Passali D, Patel Z, Peters A, Philpott C, Psaltis AJ, Ramakrishnan VR, Ramanathan M Jr, Roh HJ, Rudmik L, Sacks R, Schlosser RJ, Sedaghat AR, Senior BA, Sindwani R, Smith K, Snidvongs K, Stewart M, Suh JD, Tan BK, Turner JH, van Drunen CM, Voegels R, Wang Y, Woodworth BA, Wormald PJ, Wright ED, Yan C, Zhang L, Zhou B. International consensus statement on allergy and rhinology: rhinosinusitis 2021. Int Forum Allergy Rhinol 2021;11:213-739. [PMID: 33236525 DOI: 10.1002/alr.22741] [Cited by in Crossref: 22] [Cited by in F6Publishing: 27] [Article Influence: 22.0] [Reference Citation Analysis]
29 Keller SC, Tamma P, Salinas A, Williams D, Cosgrove SE, Gurses AP. Engaging Patients and Caregivers in a Transdisciplinary Effort to Improve Outpatient Parenteral Antimicrobial Therapy. Open Forum Infect Dis 2020;7:ofaa188. [PMID: 32617369 DOI: 10.1093/ofid/ofaa188] [Reference Citation Analysis]
30 Underwood J, Marks M, Collins S, Logan S, Pollara G. Intravenous catheter-related adverse events exceed drug-related adverse events in outpatient parenteral antimicrobial therapy. J Antimicrob Chemother 2019;74:787-90. [PMID: 30462237 DOI: 10.1093/jac/dky474] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 18.0] [Reference Citation Analysis]
31 Khan A, Wilson B, Gould IM. Current and future treatment options for community-associated MRSA infection. Expert Opin Pharmacother 2018;19:457-70. [PMID: 29480032 DOI: 10.1080/14656566.2018.1442826] [Cited by in Crossref: 27] [Cited by in F6Publishing: 23] [Article Influence: 9.0] [Reference Citation Analysis]
32 Carter B, Fisher-Smith D, Porter D, Lane S, Peak M, Taylor-Robinson D, Bracken L, Carrol ED. Paediatric Outpatient Parenteral Antimicrobial Therapy (OPAT): An e-survey of the experiences of parents and clinicians. PLoS One 2021;16:e0249514. [PMID: 33798226 DOI: 10.1371/journal.pone.0249514] [Reference Citation Analysis]
33 Chapman ALN, Patel S, Horner C, Green H, Guleri A, Hedderwick S, Snape S, Statham J, Wilson E, Gilchrist M, Seaton RA. Updated good practice recommendations for outpatient parenteral antimicrobial therapy (OPAT) in adults and children in the UK. JAC Antimicrob Resist 2019;1:dlz026. [PMID: 34222901 DOI: 10.1093/jacamr/dlz026] [Cited by in Crossref: 15] [Cited by in F6Publishing: 6] [Article Influence: 7.5] [Reference Citation Analysis]
34 Sriskandarajah S, Hobbs J, Roughead E, Ryan M, Reynolds K. Safety and effectiveness of 'hospital in the home' and 'outpatient parenteral antimicrobial therapy' in different age groups: A systematic review of observational studies. Int J Clin Pract 2018;:e13216. [PMID: 29920884 DOI: 10.1111/ijcp.13216] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]